已收录 268921 条政策
 政策提纲
  • 暂无提纲
Nutraceuticals in Prostate Disease: The Urologist’s Role
[摘要] Interest in and use of complementary and alternative therapies, especially nutraceuticals, is high in prostate disease. These therapies have shown potential in benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer. Some have produced results equal to or better than pharmaceuticals currently prescribed for BPH. In category III prostatitis, some nutraceuticals may offer relief to patients who get little from standard therapy. Because it is becoming apparent that inflammation may play a role in the progression of BPH and development of prostate cancer, nutraceuticals, which commonly have anti-inflammatory properties, may play a role. These therapies have also shown potential in prostate cancer treatment and prevention, especially those that also reduce cardiovascular events or risk. Nevertheless, uses of some nutraceuticals in prostate disease have had less desirable consequences, showing lack of efficacy, adulteration, and/or severe side effects or drug interactions. By ensuring that these therapies undergo careful study for effectiveness, quality, and safety, urologists can look forward to adding them to their evidence-based armamentarium for prostate disease.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 基础医学
[关键词] Complementary or alternative medical therapy;Nutraceuticals;Benign prostatic hyperplasia;Prostatitis;Prostate cancer [时效性] 
   浏览次数:19      统一登录查看全文      激活码登录查看全文